Skip to main content
Top
Published in: Diabetologia 1/2017

01-01-2017 | Article

Dementia onset, incidence and risk in type 2 diabetes: a matched cohort study with the Fremantle Diabetes Study Phase I

Authors: Wendy A. Davis, Renate R. Zilkens, Sergio E. Starkstein, Timothy M. E. Davis, David G. Bruce

Published in: Diabetologia | Issue 1/2017

Login to get access

Abstract

Aims/hypothesis

The study aimed to assess the incidence, age of onset, survival and relative hazard of dementia in well-categorised community-based patients with type 2 diabetes compared with a matched cohort of individuals without diabetes.

Methods

A longitudinal observational study was undertaken involving 1291 participants with type 2 diabetes from the Fremantle Diabetes Study and 5159 matched residents without documented diabetes. Linkage with health-related databases was used to detect incident dementia. Relative hazards were assessed using both cause-specific and subdistribution proportional hazards models.

Results

During 13.8 ± 5.8 years of follow-up, incident dementia occurred in 13.9% and 12.4% of the groups of participants with and without diabetes, respectively (p = 0.15). With type 2 diabetes, the incidence of dementia was higher (incidence rate ratio [IRR] 1.28, 95% CI 1.08, 1.51), as was the competing risk of death (IRR 1.50, 95% CI 1.38, 1.64). The ages when dementia was first recorded and when death with dementia occurred were both earlier with diabetes, by 1.7 (95% CI 0.6, 2.9) and 2.3 (95% CI 1.1, 3.6) years, respectively (both p ≤ 0.004). Type 2 diabetes was associated with an adjusted subdistribution HR of 1.18 (95% CI 1.00, 1.39), and a cause-specific HR of 1.51 (95% CI 1.27, 1.78) for all-cause dementia.

Conclusions/interpretation

Type 2 diabetes is associated with an increased incidence of dementia, and dementia onset occurs at a younger age. The relative hazards of both dementia and premature mortality are increased and, as a consequence, the increased risk of dementia in type 2 diabetes is not as marked as suggested by cause-specific HRs.
Appendix
Available only for authorised users
Literature
1.
go back to reference Exalto LG, Whitmer RA, Kappele LJ, Biessels GJ (2012) An update on type 2 diabetes, vascular dementia and Alzheimer’s disease. Exp Gerontol 47:858–864CrossRefPubMed Exalto LG, Whitmer RA, Kappele LJ, Biessels GJ (2012) An update on type 2 diabetes, vascular dementia and Alzheimer’s disease. Exp Gerontol 47:858–864CrossRefPubMed
2.
go back to reference Cheng G, Huang C, Deng H, Wang H (2012) Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Intern Med J 42:484–491CrossRefPubMed Cheng G, Huang C, Deng H, Wang H (2012) Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Intern Med J 42:484–491CrossRefPubMed
3.
go back to reference Gudala K, Bansal D, Schifano F, Bhansali A (2013) Diabetes mellitus and risk of dementia: a meta-analysis of prospective observational studies. J Diabetes Investig 4:640–650CrossRefPubMedPubMedCentral Gudala K, Bansal D, Schifano F, Bhansali A (2013) Diabetes mellitus and risk of dementia: a meta-analysis of prospective observational studies. J Diabetes Investig 4:640–650CrossRefPubMedPubMedCentral
4.
go back to reference Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P (2006) Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 5:64–74CrossRefPubMed Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P (2006) Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 5:64–74CrossRefPubMed
5.
go back to reference Zimmet PZ, Magliano DJ, Herman WH, Shaw JE (2014) Diabetes: a 21st century challenge. Lancet Diabetes Endocrinol 2:56–64CrossRefPubMed Zimmet PZ, Magliano DJ, Herman WH, Shaw JE (2014) Diabetes: a 21st century challenge. Lancet Diabetes Endocrinol 2:56–64CrossRefPubMed
6.
go back to reference Exalto LG, Quesenberry CP, Barnes D, Kivipelto M, Biessels GJ, Whitmer RA (2013) Midlife risk score for the prediction of dementia four decades later. Alzheimers Dement: J Alzheimers Assoc 10:562–570CrossRef Exalto LG, Quesenberry CP, Barnes D, Kivipelto M, Biessels GJ, Whitmer RA (2013) Midlife risk score for the prediction of dementia four decades later. Alzheimers Dement: J Alzheimers Assoc 10:562–570CrossRef
7.
go back to reference Biessels GJ, Strachan MW, Visseren FL, Kappelle LJ, Whitmer RA (2014) Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions. Lancet Diabetes Endocrinol 2:246–255CrossRefPubMed Biessels GJ, Strachan MW, Visseren FL, Kappelle LJ, Whitmer RA (2014) Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions. Lancet Diabetes Endocrinol 2:246–255CrossRefPubMed
8.
go back to reference Matthews FE, Arthur A, Barnes LE et al (2013) A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II. Lancet 382:1405–1412CrossRefPubMedPubMedCentral Matthews FE, Arthur A, Barnes LE et al (2013) A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II. Lancet 382:1405–1412CrossRefPubMedPubMedCentral
9.
go back to reference Qiu C, von Strauss E, Backman L, Winblad B, Fratiglioni L (2013) Twenty-year changes in dementia occurrence suggest decreasing incidence in central Stockholm, Sweden. Neurology 80:1888–1894CrossRefPubMed Qiu C, von Strauss E, Backman L, Winblad B, Fratiglioni L (2013) Twenty-year changes in dementia occurrence suggest decreasing incidence in central Stockholm, Sweden. Neurology 80:1888–1894CrossRefPubMed
10.
go back to reference Wu YT, Fratiglioni L, Matthews FE et al (2015) Dementia in western Europe: epidemiological evidence and implications for policy making. Lancet Neurol 15:116–124CrossRefPubMed Wu YT, Fratiglioni L, Matthews FE et al (2015) Dementia in western Europe: epidemiological evidence and implications for policy making. Lancet Neurol 15:116–124CrossRefPubMed
11.
go back to reference Gregg EW, Li Y, Wang J et al (2014) Changes in diabetes-related complications in the United States, 1990-2010. N Engl J Med 370:1514–1523CrossRefPubMed Gregg EW, Li Y, Wang J et al (2014) Changes in diabetes-related complications in the United States, 1990-2010. N Engl J Med 370:1514–1523CrossRefPubMed
12.
go back to reference Davis TM, Hunt K, McAullay D et al (2012) Continuing disparities in cardiovascular risk factors and complications between aboriginal and Anglo-Celt Australians with type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care 35:2005–2011CrossRefPubMedPubMedCentral Davis TM, Hunt K, McAullay D et al (2012) Continuing disparities in cardiovascular risk factors and complications between aboriginal and Anglo-Celt Australians with type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care 35:2005–2011CrossRefPubMedPubMedCentral
13.
go back to reference Berry SD, Ngo L, Samelson EJ, Kiel DP (2010) Competing risk of death: an important consideration in studies of older adults. J Am Geriatr Soc 58:783–787CrossRefPubMedPubMedCentral Berry SD, Ngo L, Samelson EJ, Kiel DP (2010) Competing risk of death: an important consideration in studies of older adults. J Am Geriatr Soc 58:783–787CrossRefPubMedPubMedCentral
14.
go back to reference Koller MT, Raatz H, Steyerberg EW, Wolbers M (2012) Competing risks and the clinical community: irrelevance or ignorance? Stat Med 31:1089–1097CrossRefPubMed Koller MT, Raatz H, Steyerberg EW, Wolbers M (2012) Competing risks and the clinical community: irrelevance or ignorance? Stat Med 31:1089–1097CrossRefPubMed
15.
go back to reference Seshasai SR, Kaptoge S, Thompson A et al (2011) Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 364:829–841CrossRefPubMed Seshasai SR, Kaptoge S, Thompson A et al (2011) Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 364:829–841CrossRefPubMed
16.
go back to reference Mayeda ER, Haan MN, Kanaya AM, Yaffe K, Neuhaus J (2013) Type 2 diabetes and 10-year risk of dementia and cognitive impairment among older Mexican Americans. Diabetes Care 36:2600–2606CrossRefPubMedPubMedCentral Mayeda ER, Haan MN, Kanaya AM, Yaffe K, Neuhaus J (2013) Type 2 diabetes and 10-year risk of dementia and cognitive impairment among older Mexican Americans. Diabetes Care 36:2600–2606CrossRefPubMedPubMedCentral
17.
go back to reference Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM (2007) Forecasting the global burden of Alzheimer’s disease. Alzheimers Dement: J Alzheimers Assoc 3:186–191CrossRef Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM (2007) Forecasting the global burden of Alzheimer’s disease. Alzheimers Dement: J Alzheimers Assoc 3:186–191CrossRef
18.
go back to reference Zilkens RR, Davis WA, Spilsbury K, Semmens JB, Bruce DG (2013) Earlier age of dementia onset and shorter survival times in dementia patients with diabetes. Am J Epidemiol 177:1246–1254CrossRefPubMed Zilkens RR, Davis WA, Spilsbury K, Semmens JB, Bruce DG (2013) Earlier age of dementia onset and shorter survival times in dementia patients with diabetes. Am J Epidemiol 177:1246–1254CrossRefPubMed
19.
go back to reference Murthy SB, Jawaid A, Qureshi SU et al (2010) Does diabetes mellitus alter the onset and clinical course of vascular dementia? Behav Neurol 23:145–151CrossRefPubMed Murthy SB, Jawaid A, Qureshi SU et al (2010) Does diabetes mellitus alter the onset and clinical course of vascular dementia? Behav Neurol 23:145–151CrossRefPubMed
20.
go back to reference Helzner EP, Scarmeas N, Cosentino S, Tang MX, Schupf N, Stern Y (2008) Survival in Alzheimer disease: a multiethnic, population-based study of incident cases. Neurology 71:1489–1495CrossRefPubMedPubMedCentral Helzner EP, Scarmeas N, Cosentino S, Tang MX, Schupf N, Stern Y (2008) Survival in Alzheimer disease: a multiethnic, population-based study of incident cases. Neurology 71:1489–1495CrossRefPubMedPubMedCentral
21.
go back to reference Davis TM, Bruce DG, Davis WA (2012) Cohort profile: The Fremantle Diabetes Study. Int J Epidemiol 42:412–421CrossRefPubMed Davis TM, Bruce DG, Davis WA (2012) Cohort profile: The Fremantle Diabetes Study. Int J Epidemiol 42:412–421CrossRefPubMed
22.
go back to reference Bruce DG, Davis WA, Casey GP et al (2008) Predictors of cognitive impairment and dementia in older people with diabetes. Diabetologia 51:241–248CrossRefPubMed Bruce DG, Davis WA, Casey GP et al (2008) Predictors of cognitive impairment and dementia in older people with diabetes. Diabetologia 51:241–248CrossRefPubMed
24.
go back to reference Bruce DG, Davis WA, Starkstein SE, Davis TM (2014) Mid-life predictors of cognitive impairment and dementia in type 2 diabetes mellitus: the Fremantle Diabetes Study. J Alzheimers Dis 42:S63–S70 Bruce DG, Davis WA, Starkstein SE, Davis TM (2014) Mid-life predictors of cognitive impairment and dementia in type 2 diabetes mellitus: the Fremantle Diabetes Study. J Alzheimers Dis 42:S63–S70
25.
go back to reference Holman CD, Bass AJ, Rouse IL, Hobbs MS (1999) Population-based linkage of health records in Western Australia: development of a health services research linked database. Aust N Z J Public Health 23:453–459CrossRefPubMed Holman CD, Bass AJ, Rouse IL, Hobbs MS (1999) Population-based linkage of health records in Western Australia: development of a health services research linked database. Aust N Z J Public Health 23:453–459CrossRefPubMed
26.
go back to reference Zilkens RR, Spilsbury K, Bruce DG, Semmens JB (2009) Linkage of hospital and death records increased identification of dementia cases and death rate estimates. Neuroepidemiology 32:61–69CrossRefPubMed Zilkens RR, Spilsbury K, Bruce DG, Semmens JB (2009) Linkage of hospital and death records increased identification of dementia cases and death rate estimates. Neuroepidemiology 32:61–69CrossRefPubMed
27.
go back to reference Zilkens RR, Spilsbury K, Bruce DG, Semmens JB (2009) Clinical epidemiology and in-patient hospital use in the last year of life (1990–2005) of 29,884 Western Australians with dementia. J Alzheimers Dis 17:399–407 Zilkens RR, Spilsbury K, Bruce DG, Semmens JB (2009) Clinical epidemiology and in-patient hospital use in the last year of life (1990–2005) of 29,884 Western Australians with dementia. J Alzheimers Dis 17:399–407
28.
go back to reference Zilkens RR, Bruce DG, Duke J, Spilsbury K, Semmens JB (2014) Severe psychiatric disorders in mid-life and risk of dementia in late- life (age 65–84 years): a population based case-control study. Curr Alzheimer Res 11:681–693 Zilkens RR, Bruce DG, Duke J, Spilsbury K, Semmens JB (2014) Severe psychiatric disorders in mid-life and risk of dementia in late- life (age 65–84 years): a population based case-control study. Curr Alzheimer Res 11:681–693
29.
go back to reference Lawrence D, Hancock KJ, Kisely S (2013) The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registers. BMJ 346:f2539CrossRefPubMedPubMedCentral Lawrence D, Hancock KJ, Kisely S (2013) The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registers. BMJ 346:f2539CrossRefPubMedPubMedCentral
30.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383CrossRefPubMed Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383CrossRefPubMed
31.
go back to reference Lambert TJ, Chapman LH, Consensus Working G (2004) Diabetes, psychotic disorders and antipsychotic therapy: a consensus statement. Med J Aust 181:544–548PubMed Lambert TJ, Chapman LH, Consensus Working G (2004) Diabetes, psychotic disorders and antipsychotic therapy: a consensus statement. Med J Aust 181:544–548PubMed
33.
go back to reference Allignol A, Schumacher M, Wanner C, Drechsler C, Beyersmann J (2011) Understanding competing risks: a simulation point of view. BMC Med Res Methodol 11:86CrossRefPubMedPubMedCentral Allignol A, Schumacher M, Wanner C, Drechsler C, Beyersmann J (2011) Understanding competing risks: a simulation point of view. BMC Med Res Methodol 11:86CrossRefPubMedPubMedCentral
34.
go back to reference Thiebaut AC, Benichou J (2004) Choice of time-scale in Cox’s model analysis of epidemiologic cohort data: a simulation study. Stat Med 23:3803–3820CrossRefPubMed Thiebaut AC, Benichou J (2004) Choice of time-scale in Cox’s model analysis of epidemiologic cohort data: a simulation study. Stat Med 23:3803–3820CrossRefPubMed
35.
go back to reference Brodaty H, Seeher K, Gibson L (2012) Dementia time to death: a systematic literature review on survival time and years of life lost in people with dementia. Int Psychogeriatr 24:1034–1045CrossRefPubMed Brodaty H, Seeher K, Gibson L (2012) Dementia time to death: a systematic literature review on survival time and years of life lost in people with dementia. Int Psychogeriatr 24:1034–1045CrossRefPubMed
36.
go back to reference Rait G, Walters K, Bottomley C, Petersen I, Iliffe S, Nazareth I (2010) Survival of people with clinical diagnosis of dementia in primary care: cohort study. BMJ 341:c3584CrossRefPubMedPubMedCentral Rait G, Walters K, Bottomley C, Petersen I, Iliffe S, Nazareth I (2010) Survival of people with clinical diagnosis of dementia in primary care: cohort study. BMJ 341:c3584CrossRefPubMedPubMedCentral
37.
go back to reference Cantegreil-Kallen I, Pin S (2012) Fear of Alzheimer’s disease in the French population: impact of age and proximity to the disease. Int Psychogeriatr 24:108–116CrossRefPubMed Cantegreil-Kallen I, Pin S (2012) Fear of Alzheimer’s disease in the French population: impact of age and proximity to the disease. Int Psychogeriatr 24:108–116CrossRefPubMed
38.
go back to reference Bogardus ST Jr, Holmboe E, Jekel JF (1999) Perils, pitfalls, and possibilities in talking about medical risk. JAMA 281:1037–1041CrossRefPubMed Bogardus ST Jr, Holmboe E, Jekel JF (1999) Perils, pitfalls, and possibilities in talking about medical risk. JAMA 281:1037–1041CrossRefPubMed
39.
go back to reference Brookmeyer R, Corrada MM, Curriero FC, Kawas C (2002) Survival following a diagnosis of Alzheimer disease. Arch Neurol 59:1764–1767CrossRefPubMed Brookmeyer R, Corrada MM, Curriero FC, Kawas C (2002) Survival following a diagnosis of Alzheimer disease. Arch Neurol 59:1764–1767CrossRefPubMed
40.
go back to reference Tuligenga RH, Dugravot A, Tabak AG et al (2014) Midlife type 2 diabetes and poor glycaemic control as risk factors for cognitive decline in early old age: a post-hoc analysis of the Whitehall II cohort study. Lancet Diabetes Endocrinol 2:228–235CrossRefPubMedPubMedCentral Tuligenga RH, Dugravot A, Tabak AG et al (2014) Midlife type 2 diabetes and poor glycaemic control as risk factors for cognitive decline in early old age: a post-hoc analysis of the Whitehall II cohort study. Lancet Diabetes Endocrinol 2:228–235CrossRefPubMedPubMedCentral
41.
go back to reference Henderson T, Shepheard J, Sundararajan V (2006) Quality of diagnosis and procedure coding in ICD-10 administrative data. Med Care 44:1011–1019CrossRefPubMed Henderson T, Shepheard J, Sundararajan V (2006) Quality of diagnosis and procedure coding in ICD-10 administrative data. Med Care 44:1011–1019CrossRefPubMed
42.
go back to reference Phung TK, Andersen BB, Hogh P, Kessing LV, Mortensen PB, Waldemar G (2007) Validity of dementia diagnoses in the Danish hospital registers. Dement Geriatr Cogn Disord 24:220–228CrossRefPubMed Phung TK, Andersen BB, Hogh P, Kessing LV, Mortensen PB, Waldemar G (2007) Validity of dementia diagnoses in the Danish hospital registers. Dement Geriatr Cogn Disord 24:220–228CrossRefPubMed
Metadata
Title
Dementia onset, incidence and risk in type 2 diabetes: a matched cohort study with the Fremantle Diabetes Study Phase I
Authors
Wendy A. Davis
Renate R. Zilkens
Sergio E. Starkstein
Timothy M. E. Davis
David G. Bruce
Publication date
01-01-2017
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 1/2017
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-016-4127-9

Other articles of this Issue 1/2017

Diabetologia 1/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.